glp 1 for weight loss fda approved Approves First-Of-Its-Kind Oral GLP-1 Article » ProAct

Pharmaceutical Industry: It plays a crucial role in drug formulation, particularly in the development of therapies for conditions related to oxidative damage, such as neurodegenerative diseases

FDA-approved candidates include adults with BMI 30 kg/m or BMI 27 kg/m with weight-related comorbidities such as hypertension, dyslipidemia, or cardiovascular disease

The formal compound name is Retatrutide and the investigational designation is LY-3437943

doi: 10.1016/j.neulet.2021.136342 122

It is often called a stable gastric pentadecapeptide because, unlike many peptides, it stays stable in gastric acid rather than breaking down on contact